Status:
UNKNOWN
Impact of Thoracic Epidural Versus Serratus Anterior Plane Block Versus Erector Spinae Plane Block on Incidence of PTPS
Lead Sponsor:
National Cancer Institute, Egypt
Conditions:
Post-thoracotomy Pain Syndrome
Erector Spinae Plane Block
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The aim of this study is to evaluate the impact of Ultrasound-guided Erector Spinae plane block compared to Ultrasound-guided serratus anterior plane block on the emergence of post-thoracotomy pain sy...
Detailed Description
Lung cancer has the highest incidence of all malignancies worldwide and accounts for approximately 13% of all cancer cases. Lung cancer is still the most common cause of cancer-related deaths, and lun...
Eligibility Criteria
Inclusion
- Age (18-65) Years
- Physical status American Society of Anesthesiologists Classification II, III
- Patients undergoing lobectomy through lateral thoracotomy
- Body mass index (BMI): (20-40) kg/m2
Exclusion
- Patient refusal.
- Age \<18 years or \>65 years
- Body mass index (BMI) \<20 kg/m2 and \>40 kg/m2
- Known sensitivity or contraindication to drugs used in the study
- Contraindication to regional anesthesia e.g. local infection at site of introduction, pre-existing peripheral neuropathies and coagulopathy.
- Pregnancy.
- Physical status American Society of Anesthesiologists Classification IV
- patients on chronic analgesic therapy (daily morphine ≥30 mg or equivalent dose of other opioids or tramadol or any medication for neuropathic pain)
- patients with a history of drug abuse
- patients with neuropsychiatric diseases; patients with a history of chronic pain syndromes that may enhance sensitivity to pain, for example, fibromyalgia
- patients with a history of thoracic surgery through lateral thoracotomy; and patients with recurrent chest malignancies within 3 months.
- All patients who developed severe intra- or post-operative bleeding or required postoperative mechanical ventilation were also excluded from the study.
- Thoracic spine disorders or deformity.
Key Trial Info
Start Date :
June 20 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2023
Estimated Enrollment :
111 Patients enrolled
Trial Details
Trial ID
NCT05409144
Start Date
June 20 2022
End Date
April 1 2023
Last Update
June 8 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.